Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Perrillo

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Clinical Therapeutics|March 1, 1994
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact ProfileG L Davis, L A Balart, E R Schiff, et al.
Gastroenterology|February 1, 1993
Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy GroupJ H Lefkowitch, E R Schiff, G L Davis, et al.
The Journal of Infectious Diseases|February 1, 1995
Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United StatesJ Y Lau, M Mizokami, J A Kolberg, et al.
The New England Journal of Medicine|October 21, 1999
Lamivudine as initial treatment for chronic hepatitis B in the United StatesJ L Dienstag, E R Schiff, T L Wright, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis BR P Perrillo, T Wright, J Rakela, et al.
The New England Journal of Medicine|December 31, 1992
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study GroupL B Seeff, Z Buskell-Bales, E C Wright, et al.
The Journal of Infectious Diseases|March 1, 1990
Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipientsL Marsano, R P Perrillo, M W Flye, et al.
Hepatology (Baltimore, Md.)|January 27, 1999
Association of diabetes mellitus and chronic hepatitis C virus infectionA L Mason, J Y Lau, N Hoang, et al.
The New England Journal of Medicine|August 2, 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy GroupR P Perrillo, E R Schiff, G L Davis, et al.
Hepatology (Baltimore, Md.)|November 1, 1996
Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy GroupK L Lindsay, G L Davis, E R Schiff, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Clinical Therapeutics|March 1, 1994
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact ProfileG L Davis, L A Balart, E R Schiff, et al.
Gastroenterology|February 1, 1993
Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy GroupJ H Lefkowitch, E R Schiff, G L Davis, et al.
The Journal of Infectious Diseases|February 1, 1995
Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United StatesJ Y Lau, M Mizokami, J A Kolberg, et al.
The New England Journal of Medicine|October 21, 1999
Lamivudine as initial treatment for chronic hepatitis B in the United StatesJ L Dienstag, E R Schiff, T L Wright, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis BR P Perrillo, T Wright, J Rakela, et al.
The New England Journal of Medicine|December 31, 1992
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study GroupL B Seeff, Z Buskell-Bales, E C Wright, et al.
The Journal of Infectious Diseases|March 1, 1990
Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipientsL Marsano, R P Perrillo, M W Flye, et al.
Hepatology (Baltimore, Md.)|January 27, 1999
Association of diabetes mellitus and chronic hepatitis C virus infectionA L Mason, J Y Lau, N Hoang, et al.
The New England Journal of Medicine|August 2, 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy GroupR P Perrillo, E R Schiff, G L Davis, et al.
Hepatology (Baltimore, Md.)|November 1, 1996
Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy GroupK L Lindsay, G L Davis, E R Schiff, et al.
Pageof 10